It was a huge hit
Zhao L, Jin L, Petrick JL et al (2023) Specific botanical groups of fruit and vegetable consumption and liver cancer and chronic liver disease mortality: a prospective cohort study
Women who benefit most are those who struggle with: Insulin resistance Emotional eating Excess visceral fat Joint strain from obesity Fatigue limiting movement Used properly, GLP-1 helps build a healthier platform for everything else to work better
The 68-week study showed participants on CagriSema lost about 23% of their body weight, compared with 12% for those taking cagrilintide by itself, 16% for those on semaglutide, and 2.3% for people on a placebo
Key risk mitigation strategies include patient education on the signs of lactic acidosis, ketoacidosis and dehydration, along with regular monitoring by a healthcare provider. References and Editorial Review The information on this page is based on clinical studies and peer-reviewed medical journals
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes